跳至主要内容
临床试验/CTRI/2026/07/113888
CTRI/2026/07/113888进行中(未招募)2/3 期

An Open Label Randomized Controlled Clinical Study to Evaluate the Efficacy of Kamadugha Rasa Muktayukta Kharjuradi Mantha and Dadimadi Ghritha as an Adjuvant in Managing the Side Effects and Improving the Quality of Life of Subjects Undergoing Chemotherapy in Cancer - NIL

Dr Rajasri S0 个研究点目标入组 40 人开始时间: 2026年7月26日最近更新:

试验速览

阶段
2/3 期
状态
进行中(未招募)
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients aged 18 to 80 years.
  • Diagnosed cases of cancer irrespective of type or site.
  • Undergoing chemotherapy.
  • Patients who have completed at least one cycle of chemotherapy.
  • Willing to participate and provide written informed consent.

排除标准

  • Patients unable to take oral medications.
  • Terminally ill patients.
  • Patients with uncontrolled diabetes mellitus.
  • Patients with uncontrolled hypertension.
  • Patients with severe systemic disorders likely to interfere with the study.

研究者

发起方
Dr Rajasri S

相似试验